Osteosarcoma - Pipeline Review, H1 2016; New Report Launched
Osteosarcoma - Pipeline Review, H1 2016 report provides an overview of the Osteosarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
View full press release